Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.
Clinical trial NCT03640221 · WITHDRAWN
Trial details
- NCT number
- NCT03640221
- Sponsor
- Cedars-Sinai Medical Center
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-01
- Primary completion
- 2020-05-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.